NDT Pharmaceuticals Inc. (NDTP)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -79.02 Thousand USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2017 | -1240.00 USD | 35.75% |
| 2016 | -1929.00 USD | 97.79% |
| 2015 | -87.33 Thousand USD | 66.5% |
| 2014 | -260.67 Thousand USD | 0.0% |
| 2010 | -246.24 Thousand USD | 0.0% |
| 2007 | -59.93 Thousand USD | 1915.39% |
| 2006 | -51.76 Thousand USD | -796.6% |
| 2005 | -5773.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1520.00 USD | 44.12% |
| 2024 Q3 | -2200.00 USD | 78.36% |
| 2024 Q2 | -10.17 Thousand USD | -568.82% |
| 2023 Q4 | -2720.00 USD | -32.04% |
| 2023 FY | - USD | 0.0% |
| 2023 Q1 | -11.26 Thousand USD | 0.0% |
| 2023 Q2 | -9130.00 USD | 18.92% |
| 2023 Q3 | -2060.00 USD | 77.44% |
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2017 FY | - USD | 35.75% |
| 2016 FY | - USD | 97.79% |
| 2015 FY | - USD | 66.5% |
| 2014 FY | - USD | 0.0% |
| 2011 Q1 | -19.9 Thousand USD | -13.0% |
| 2011 Q2 | -9490.00 USD | 52.31% |
| 2010 Q1 | -12.95 Thousand USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | -17.61 Thousand USD | -69.82% |
| 2010 Q3 | -10.37 Thousand USD | 94.95% |
| 2010 Q2 | -205.31 Thousand USD | -1485.41% |
| 2008 Q1 | 3563.00 USD | 116.7% |
| 2008 Q2 | -5119.00 USD | -243.67% |
| 2007 Q3 | -18.14 Thousand USD | -53.75% |
| 2007 FY | - USD | 1915.39% |
| 2007 Q4 | -21.33 Thousand USD | -17.62% |
| 2007 Q1 | -10.15 Thousand USD | 49.36% |
| 2007 Q2 | -11.8 Thousand USD | -16.23% |
| 2006 Q4 | -20.04 Thousand USD | -159.73% |
| 2006 Q2 | -3761.00 USD | 81.39% |
| 2006 Q1 | -20.2 Thousand USD | 0.0% |
| 2006 Q3 | -7718.00 USD | -105.21% |
| 2006 FY | - USD | -796.6% |
| 2005 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 99.889% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 98.667% |
| SQZ Biotechnologies Company | -64.14 Million USD | 99.877% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 99.545% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 100.084% |
| Mesoblast Limited | -62.38 Million USD | 99.873% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 94.855% |
| Genus plc | 73.7 Million USD | 100.107% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 98.805% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 97.772% |
| Marizyme, Inc. | -34.28 Million USD | 99.769% |
| ContraFect Corporation | -64.99 Million USD | 99.878% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 99.099% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 98.254% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 94.362% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 97.012% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 96.599% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | 84.745% |
| Accustem Sciences Inc. | -3.74 Million USD | 97.891% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 99.836% |
| EV Biologics, Inc. | -1.26 Million USD | 93.763% |
| Q BioMed Inc. | -617.62 Thousand USD | 87.204% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 102.212% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 87.503% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 96.541% |
| Biomind Labs Inc. | -1.03 Million USD | 92.361% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 100.8% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 98.896% |
| Skye Bioscience, Inc. | -13.54 Million USD | 99.417% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 94.687% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -216.116% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 97.965% |
| IMV Inc. | -35.52 Million USD | 99.778% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 99.502% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 96.841% |
| GB Sciences, Inc. | -1.41 Million USD | 94.434% |
| Alpha Cognition Inc. | -9.7 Million USD | 99.186% |
| HST Global, Inc. | -5303.00 USD | -1390.27% |
| CSL Limited | 4.78 Billion USD | 100.002% |
| Halberd Corporation | -74.27 Thousand USD | -6.395% |
| Enzolytics Inc. | -2.12 Million USD | 96.276% |
| Resverlogix Corp. | -11.74 Million USD | 99.327% |
| Affymax, Inc. | -14.29 Million USD | 99.447% |
| SYBLEU INC | -141.57 Thousand USD | 44.177% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 97.42% |
| argenx SE | -216.02 Million USD | 99.963% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 99.857% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 106.494% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 94.728% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 120.861% |
| AVAX Technologies, Inc. | -6.11 Million USD | 98.707% |
| Zenith Capital Corp. | -8.6 Million USD | 99.082% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.968% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -353.642% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 96.77% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | 55.103% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 99.801% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 97.268% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | 92.447% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 1275.327% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 95.484% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 95.886% |
| BioStem Technologies, Inc. | -7.55 Million USD | 98.954% |
| ONE Bio Corp. | 13.61 Million USD | 100.581% |
| Reve Technologies, Inc. | -181.08 Thousand USD | 56.359% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 96.158% |
| Agentix Corp. | -1.37 Million USD | 94.239% |
| LadRx Corporation | 412.28 Thousand USD | 119.169% |
| Cell Source, Inc. | -4.27 Million USD | 98.15% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | 78.479% |
| Regen BioPharma, Inc. | 1.46 Million USD | 105.391% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | 91.565% |
| NovAccess Global Inc. | -1.03 Million USD | 92.363% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 100.893% |
| Itoco Inc. | -1.86 Million USD | 95.772% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | 79.182% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 92.919% |
| Kadimastem Ltd | -2.62 Million USD | 96.989% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | 66.954% |
| CytoDyn Inc. | -18.02 Million USD | 99.562% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | -2.24 Million USD | 96.474% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -546.243% |
| Qrons Inc. | -40.08 Thousand USD | -97.173% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | 83.728% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 114.984% |
| Rebus Holdings, Inc. | -951 Thousand USD | 91.69% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | 92.559% |
| International Stem Cell Corporation | 202 Thousand USD | 139.123% |
| Bioxytran, Inc. | -3.82 Million USD | 97.931% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -50.131% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 96.79% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 99.78% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -75.62% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 97.114% |
| Neutra Corp. | -181.24 Thousand USD | 56.397% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 99.608% |
| PureTech Health plc | -11.62 Million USD | 99.32% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 99.608% |
| IXICO plc | -707 Thousand USD | 88.822% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 98.972% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 99.837% |
| CSL Limited | 4.73 Billion USD | 100.002% |
| Cellectis S.A. | -92.63 Million USD | 99.915% |